Gregory Scott Duncan - 22 Feb 2022 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Director
Signature
/s/ Gregory Scott Duncan
Issuer symbol
CRMD
Transactions as of
22 Feb 2022
Net transactions value
$0
Form type
4
Filing time
23 Feb 2022, 15:23:05 UTC
Previous filing
22 Dec 2021
Next filing
24 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Award $0 +20,000 $0.000000 20,000 22 Feb 2022 Common Stock 20,000 $4.03 Direct F4
holding CRMD Stock Option (Right to Buy Common Stock) 20,000 22 Feb 2022 Common Stock 20,000 $8.32 Direct F1
holding CRMD Stock Option (Right to Buy Common Stock) 20,000 22 Feb 2022 Common Stock 20,000 $5.00 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 2,500 22 Feb 2022 Common Stock 2,500 $5.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on 1/11/2021. These options are fully vested.
F2 These options were granted on 11/02/2020. One-third of the options vested on the date of grant. One-third of the options will vest on each of the first and second anniversaries of the date of grant, subject to continued service on the board.
F3 These options were granted on 11/02/2020. These options are fully vested.
F4 These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.